Zhengye Biotechnology Holding Limited (NAS: ZYBT) Stock Analysis & Fundamentals

ZYBTZhengye Biotechnology Holding Limited

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · jlzybio.com

1.890USD+2.16%Mkt Cap: 89.57M $P/E: —1d ago

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goa…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap89.57M $

Enterprise Value169.63M $

Revenue (TTM)116.36M $

Gross Profit23.87M $

Net Income (TTM)-69.78M $

Revenue/Share2.457 USD

Last Price1.890 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees269

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-3.80

EV/Revenue1.46

P/S0.77

P/B2.42

EPS (TTM)-0.22

EPS (Forward)—

52W Range

1.51059% of range2.155

52W High2.155 USD

52W Low1.510 USD

Profitability

Gross Margin20.51%

Oper. Margin-77.04%

EBITDA Margin-38.35%

Profit Margin-59.97%

ROE-27.93%

ROA-15.99%

Growth

Revenue Growth-40.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF13.33M $

CapEx (TTM)12.63M $

FCF Margin34.01%

FCF Yield44.19%

Net Debt23.19M $

Net Debt/EBITDA-0.52

Balance Sheet

Debt/Equity0.30

Current Ratio1.14

Quick Ratio0.58

Book Value/Sh0.7818 USD

Cash/Share1.095 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.47.39M

Float6.26M

Insiders16.16%

Institutions0.91%

Short Interest

Short Ratio0.0d

Short % Float0.65%

Short % Out.0.63%

Shares Short296.92K

Short (prev mo.)43.52K

Technical

SMA 501.320 (+43.2%)

SMA 2001.247 (+51.6%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)641.30K

Avg Vol (10d)1.65M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—